GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Shanghai Rongtai Health Technology Corp Ltd (SHSE:603579) » Definitions » Debt-to-Equity

Shanghai Rongtai Health Technology (SHSE:603579) Debt-to-Equity : 0.52 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shanghai Rongtai Health Technology Debt-to-Equity?

Shanghai Rongtai Health Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥360 Mil. Shanghai Rongtai Health Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥649 Mil. Shanghai Rongtai Health Technology's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥1,942 Mil. Shanghai Rongtai Health Technology's debt to equity for the quarter that ended in Sep. 2024 was 0.52.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai Rongtai Health Technology's Debt-to-Equity or its related term are showing as below:

SHSE:603579' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.29   Max: 0.54
Current: 0.52

During the past 13 years, the highest Debt-to-Equity Ratio of Shanghai Rongtai Health Technology was 0.54. The lowest was 0.02. And the median was 0.29.

SHSE:603579's Debt-to-Equity is ranked worse than
54.14% of 689 companies
in the Travel & Leisure industry
Industry Median: 0.44 vs SHSE:603579: 0.52

Shanghai Rongtai Health Technology Debt-to-Equity Historical Data

The historical data trend for Shanghai Rongtai Health Technology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Rongtai Health Technology Debt-to-Equity Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.35 0.39 0.54 0.38

Shanghai Rongtai Health Technology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.38 0.43 0.45 0.52

Competitive Comparison of Shanghai Rongtai Health Technology's Debt-to-Equity

For the Leisure subindustry, Shanghai Rongtai Health Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rongtai Health Technology's Debt-to-Equity Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai Rongtai Health Technology's Debt-to-Equity falls into.



Shanghai Rongtai Health Technology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai Rongtai Health Technology's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shanghai Rongtai Health Technology's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Rongtai Health Technology  (SHSE:603579) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Shanghai Rongtai Health Technology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Rongtai Health Technology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rongtai Health Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 1226 Zhu Feng Road, Qingpu District, Shanghai, CHN, 201714
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
Executives
Cao Tao Supervisors
Ying Jian Sen Director
Lin Guang Sheng Director
Lin Qi Director

Shanghai Rongtai Health Technology Headlines

No Headlines